NES Flu A/B & COVID-19
Device
DiaSorin Molecular LLC
Total Payments
$1.0M
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $730,788 | 1 | 0 |
| 2022 | $276,121 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.0M | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NES Flu A/B & COVID-19 Clinical Study (Project DD20-012) | DiaSorin Molecular LLC | $1.0M | 0 |
Top Doctors Receiving Payments for NES Flu A/B & COVID-19
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Land O' Lakes, FL | $1.0M | 3 |
Ad
Manufacturing Companies
- DiaSorin Molecular LLC $1.0M
Product Information
- Type Device
- Total Payments $1.0M
- Total Doctors 0
- Transactions 3
About NES Flu A/B & COVID-19
NES Flu A/B & COVID-19 is a device associated with $1.0M in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Molecular LLC.
Payment data is available from 2022 to 2023. In 2023, $730,788 was paid across 1 transactions to 0 doctors.
The most common payment nature for NES Flu A/B & COVID-19 is "Unspecified" ($1.0M, 100.0% of total).
NES Flu A/B & COVID-19 is associated with 1 research study, including "NES Flu A/B & COVID-19 Clinical Study (Project DD20-012)" ($1.0M).